NCT04392271View on ClinicalTrials.gov

A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

October 14, 2020

Study Completion Date

October 14, 2020

Conditions
Healthy
Interventions
DRUG

LY3372689

Administered orally.

DIAGNOSTIC_TEST

[18F]LSN3316612

Administered intravenously (IV).

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04392271 - A Study of the Effects of Multiple Doses of LY3372689 on the Brain in Healthy Participants | Biotech Hunter | Biotech Hunter